Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 5/20 | 0.61 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.53 |
| ▸ | TGFBR1 | P36897 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | LARS1 | Q9P2J5 | 2/20 | 0.45 |
| ▸ | LAP3 | P28838 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.43 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8945299 | 1.00 | MME (0.61) | MMESLC7A5TGFBR1ALDH1A1MAPT | |
| SCHEMBL30600472 | 1.00 | MME (0.61) | MMESLC7A5TGFBR1ALDH1A1MAPT | |
| SCHEMBL30123121 | 0.97 | MME (0.58) | MMESLC7A5TGFBR1ALDH1A1MAPT | |
| SCHEMBL29788251 | 0.95 | MME (0.56) | MMESLC7A5TGFBR1ALDH1A1MAPT | |
| SCHEMBL30662328 | 0.95 | MME (0.56) | MMESLC7A5TGFBR1ALDH1A1MAPT | |
| Dimethyl Sulfone SCHEMBL17165618 | 0.95 | MME (0.56) | MMESLC7A5TGFBR1ALDH1A1MAPT | |
| Dimethyl Sulfone SCHEMBL17165619 | 0.95 | MME (0.56) | MMESLC7A5TGFBR1ALDH1A1MAPT | |
| SCHEMBL29406037 | 0.94 | MME (0.55) | MMESLC7A5TGFBR1ALDH1A1MAPT | |
| SCHEMBL29725304 | 0.94 | MME (0.55) | MMESLC7A5TGFBR1ALDH1A1MAPT | |
| SCHEMBL29351939 | 0.92 | MME (0.53) | MMESLC7A5ALDH1A1MAPTLAP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4659591-A1 | TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT | House Foods Group Inc. (JP) | 2025-12-10 | — | — | EP | claimed |
| CN-117969859-B | Metabolic biomarker for polycystic ovary syndrome and application thereof | 山东大学 | 2024-09-06 | — | — | CN | claimed |
| CN-118453439-A | Use of biologically active polypeptides in oral care | 云南白药集团股份有限公司 | 2024-08-09 | — | — | CN | claimed |
| WO-2024162422-A1 | TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT | ハウス食品グループ本社株式会社 | 2024-08-08 | — | — | WO | claimed |
| EP-4370919-A1 | METABOLIC SIGNATURE FOR PREDICTION OF MUCOSAL INFLAMMATION AND MICROBIAL COMPOSITION | Imperial College Innovations Limited (GB) | 2024-05-22 | — | — | EP | claimed |
| CN-117969859-A | Metabolic biomarker for polycystic ovary syndrome and application thereof | 山东大学 | 2024-05-03 | — | — | CN | claimed |
| CN-116948008-A | Preparation method of salmon calcitonin | 上海苏豪逸明制药有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-116041476-B | MALK derived from pig liver to express antibacterial peptide, and preparation method and application thereof | 东北农业大学 | 2023-10-27 | — | — | CN | claimed |
| CN-114456254-B | Synthesis method of C-type natriuretic peptide analogue Vosoritide | 江苏诺泰澳赛诺生物制药股份有限公司 | 2023-06-16 | — | — | CN | claimed |
| CN-116041476-A | MALK derived from pig liver to express antibacterial peptide, and preparation method and application thereof | 东北农业大学 | 2023-05-02 | — | — | CN | claimed |
| WO-2023285832-A1 | METABOLIC SIGNATURE FOR PREDICTION OF MUCOSAL INFLAMMATION AND MICROBIAL COMPOSITION | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2023-01-19 | — | — | WO | claimed |
| CN-112175066-B | Method for preparing sertraline | 浙江苏泊尔制药有限公司 | 2022-12-02 | — | — | CN | claimed |
| EP-4720030-A1 | ASYMMETRIC PHENYLALKYLAMINES | Alexander Shulgin Research Institute, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| EP-4710949-A1 | LYOPHILIZED PREPARATION, LYOPHILIZED SOLUTION, METHODS FOR PRODUCING SAME, AND LIQUID AGENT | Goryo Chemical, Inc. (JP) | 2026-03-18 | — | — | EP | disclosed |
| EP-4695413-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | Ohio State Innovation Foundation (US) | 2026-02-18 | — | — | EP | disclosed |
| EP-4673127-A1 | DEUTERATED AND FLUORINATED EMPATHOGENS | Alexander Shulgin Research Institute, Inc. (US) | 2026-01-07 | — | — | EP | disclosed |
| US-4346104-A | ANTIINFLAMMATORY | CIBA-GEIGY CORPORATION (US) | 1982-08-24 | — | — | US | disclosed |
| US-4346105-A | ANTIINFLAMMATORY AGENTS | CIBA-GEIGY CORPORATION (US) | 1982-08-24 | — | — | US | disclosed |
| US-4322436-A | ANTIINFLAMMATORY AGENTS | CIBA-GEIGY CORPORATION (US) | 1982-03-30 | — | — | US | disclosed |
| US-4250192-A | ANTIINFLAMMATORY AGENTS | CIBA-GEIGY CORPORATION (US) | 1981-02-10 | — | — | US | disclosed |